430 related articles for article (PubMed ID: 16026583)
1. Acid and neutral sphingomyelinase, ceramide synthase, and acid ceramidase activities in cutaneous aging.
Jensen JM; Förl M; Winoto-Morbach S; Seite S; Schunck M; Proksch E; Schütze S
Exp Dermatol; 2005 Aug; 14(8):609-18. PubMed ID: 16026583
[TBL] [Abstract][Full Text] [Related]
2. Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier.
Jensen JM; Schütze S; Förl M; Krönke M; Proksch E
J Clin Invest; 1999 Dec; 104(12):1761-70. PubMed ID: 10606630
[TBL] [Abstract][Full Text] [Related]
3. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin.
Man MQ; Feingold KR; Elias PM
Arch Dermatol; 1993 Jun; 129(6):728-38. PubMed ID: 8507075
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis.
Hatano Y; Terashi H; Arakawa S; Katagiri K
J Invest Dermatol; 2005 Apr; 124(4):786-92. PubMed ID: 15816837
[TBL] [Abstract][Full Text] [Related]
5. Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis.
Schmuth M; Man MQ; Weber F; Gao W; Feingold KR; Fritsch P; Elias PM; Holleran WM
J Invest Dermatol; 2000 Sep; 115(3):459-66. PubMed ID: 10951284
[TBL] [Abstract][Full Text] [Related]
6. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis.
Jensen JM; Fölster-Holst R; Baranowsky A; Schunck M; Winoto-Morbach S; Neumann C; Schütze S; Proksch E
J Invest Dermatol; 2004 Jun; 122(6):1423-31. PubMed ID: 15175033
[TBL] [Abstract][Full Text] [Related]
7. p53-Independent ceramide formation in human glioma cells during gamma-radiation-induced apoptosis.
Hara S; Nakashima S; Kiyono T; Sawada M; Yoshimura S; Iwama T; Banno Y; Shinoda J; Sakai N
Cell Death Differ; 2004 Aug; 11(8):853-61. PubMed ID: 15088070
[TBL] [Abstract][Full Text] [Related]
8. Impaired cutaneous permeability barrier function, skin hydration, and sphingomyelinase activity in keratin 10 deficient mice.
Jensen JM; Schütze S; Neumann C; Proksch E
J Invest Dermatol; 2000 Oct; 115(4):708-13. PubMed ID: 10998148
[TBL] [Abstract][Full Text] [Related]
9. Epidermal ceramidase activity regulates epidermal desquamation via stratum corneum acidification.
Houben E; Hachem JP; De Paepe K; Rogiers V
Skin Pharmacol Physiol; 2008; 21(2):111-8. PubMed ID: 18253067
[TBL] [Abstract][Full Text] [Related]
10. The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide.
Higuchi K; Hara J; Okamoto R; Kawashima M; Imokawa G
Biochem J; 2000 Sep; 350 Pt 3(Pt 3):747-56. PubMed ID: 10970788
[TBL] [Abstract][Full Text] [Related]
11. Ceramide biosynthesis in keratinocyte and its role in skin function.
Mizutani Y; Mitsutake S; Tsuji K; Kihara A; Igarashi Y
Biochimie; 2009 Jun; 91(6):784-90. PubMed ID: 19364519
[TBL] [Abstract][Full Text] [Related]
12. Psyllium and fat in diets differentially affect the activities and expressions of colonic sphingomyelinases and caspase in mice.
Cheng Y; Ohlsson L; Duan RD
Br J Nutr; 2004 May; 91(5):715-23. PubMed ID: 15137923
[TBL] [Abstract][Full Text] [Related]
13. A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide.
Imokawa G
J Dermatol Sci; 2009 Jul; 55(1):1-9. PubMed ID: 19443184
[TBL] [Abstract][Full Text] [Related]
14. Effect of the lactic acid bacterium Streptococcus thermophilus on ceramide levels in human keratinocytes in vitro and stratum corneum in vivo.
Di Marzio L; Cinque B; De Simone C; Cifone MG
J Invest Dermatol; 1999 Jul; 113(1):98-106. PubMed ID: 10417626
[TBL] [Abstract][Full Text] [Related]
15. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model.
Ghadially R; Brown BE; Sequeira-Martin SM; Feingold KR; Elias PM
J Clin Invest; 1995 May; 95(5):2281-90. PubMed ID: 7738193
[TBL] [Abstract][Full Text] [Related]
16. Expression of intestinal and lung alkaline sphingomyelinase and neutral ceramidase in cystic fibrosis f508del transgenic mice.
Ohlsson L; Hjelte L; Hühn M; Scholte BJ; Wilke M; Flodström-Tullberg M; Nilsson A
J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):547-54. PubMed ID: 18955860
[TBL] [Abstract][Full Text] [Related]
17. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis.
Harris IR; Farrell AM; Grunfeld C; Holleran WM; Elias PM; Feingold KR
J Invest Dermatol; 1997 Dec; 109(6):783-7. PubMed ID: 9406821
[TBL] [Abstract][Full Text] [Related]
18. Th1 cytokines accentuate but Th2 cytokines attenuate ceramide production in the stratum corneum of human epidermal equivalents: an implication for the disrupted barrier mechanism in atopic dermatitis.
Sawada E; Yoshida N; Sugiura A; Imokawa G
J Dermatol Sci; 2012 Oct; 68(1):25-35. PubMed ID: 22884781
[TBL] [Abstract][Full Text] [Related]
19. Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma.
Hertervig E; Nilsson A; Nyberg L; Duan RD
Cancer; 1997 Feb; 79(3):448-53. PubMed ID: 9028353
[TBL] [Abstract][Full Text] [Related]
20. Basis for enhanced barrier function of pigmented skin.
Man MQ; Lin TK; Santiago JL; Celli A; Zhong L; Huang ZM; Roelandt T; Hupe M; Sundberg JP; Silva KA; Crumrine D; Martin-Ezquerra G; Trullas C; Sun R; Wakefield JS; Wei ML; Feingold KR; Mauro TM; Elias PM
J Invest Dermatol; 2014 Sep; 134(9):2399-2407. PubMed ID: 24732399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
